Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Roc domain of leucine‐rich repeat kinase 2 is sufficient for interaction with microtubules
Payal N. Gandhi, Xinglong Wang, Xiongwei Zhu, et al.
Journal of Neuroscience Research (2008) Vol. 86, Iss. 8, pp. 1711-1720
Open Access | Times Cited: 169

Showing 26-50 of 169 citing articles:

Manganese-Induced Dopaminergic Neurodegeneration: Insights into Mechanisms and Genetics Shared with Parkinson’s Disease
Alexandre Benedetto, Catherine Au, Michael Aschner
Chemical Reviews (2009) Vol. 109, Iss. 10, pp. 4862-4884
Closed Access | Times Cited: 121
Leucine‐rich repeat kinase 2 (LRRK2): A key player in the pathogenesis of Parkinson's disease
Payal N. Gandhi, Shu G. Chen, Amy L. Wilson‐Delfosse
Journal of Neuroscience Research (2008) Vol. 87, Iss. 6, pp. 1283-1295
Open Access | Times Cited: 120
Investigation of leucine‐rich repeat kinase 2
Vasanti S. Anand, Laurie J. Reichling, Kerri Lipinski, et al.
FEBS Journal (2008) Vol. 276, Iss. 2, pp. 466-478
Closed Access | Times Cited: 109
The WD40 Domain Is Required for LRRK2 Neurotoxicity
Nathan D. Jorgensen, Yong Peng, Cherry Cheng-Ying Ho, et al.
PLoS ONE (2009) Vol. 4, Iss. 12, pp. e8463-e8463
Open Access | Times Cited: 107
LRRK2 Kinase Activity Is Dependent on LRRK2 GTP Binding Capacity but Independent of LRRK2 GTP Binding
Jean‐Marc Taymans, Renée Vancraenenbroeck, Petri Ollikainen, et al.
PLoS ONE (2011) Vol. 6, Iss. 8, pp. e23207-e23207
Open Access | Times Cited: 101
Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson's disease
Saskia Biskup, Andrew B. West
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2008) Vol. 1792, Iss. 7, pp. 625-633
Open Access | Times Cited: 100
Biochemical Characterization of Highly Purified Leucine-Rich Repeat Kinases 1 and 2 Demonstrates Formation of Homodimers
Laura Civiero, Renée Vancraenenbroeck, Elisa Belluzzi, et al.
PLoS ONE (2012) Vol. 7, Iss. 8, pp. e43472-e43472
Open Access | Times Cited: 99
Mitochondrial Quality Control and Dynamics in Parkinson's Disease
Melissa K. McCoy, Mark Cookson
Antioxidants and Redox Signaling (2011) Vol. 16, Iss. 9, pp. 869-882
Open Access | Times Cited: 98
Pathogenesis of familial Parkinson’s disease: new insights based on monogenic forms of Parkinson’s disease
Taku Hatano, Shinichiro Kubo, Shigeto Sato, et al.
Journal of Neurochemistry (2009) Vol. 111, Iss. 5, pp. 1075-1093
Open Access | Times Cited: 96
The LRRK2 inhibitor GSK2578215A induces protective autophagy in SH-SY5Y cells: involvement of Drp-1-mediated mitochondrial fission and mitochondrial-derived ROS signaling
Sara Sáez-Atiénzar, Luis Bonet‐Ponce, Rafael Blesa, et al.
Cell Death and Disease (2014) Vol. 5, Iss. 8, pp. e1368-e1368
Open Access | Times Cited: 93
LRRK2, a puzzling protein: Insights into Parkinson's disease pathogenesis
A. Raquel Esteves, Russell H. Swerdlow, Sandra M. Cardoso
Experimental Neurology (2014) Vol. 261, pp. 206-216
Open Access | Times Cited: 93
Mitochondrial Dysfunction in Genetic Animal Models of Parkinson's Disease
Alžbeta Trančíková, Elpida Tsika, Darren J. Moore
Antioxidants and Redox Signaling (2011) Vol. 16, Iss. 9, pp. 896-919
Open Access | Times Cited: 88
Injury-induced immune responses in Hydra
Yvan Wenger, Wanda Buzgariu, Silke Reiter, et al.
Seminars in Immunology (2014) Vol. 26, Iss. 4, pp. 277-294
Open Access | Times Cited: 88
LRRK2 signaling pathways: the key to unlocking neurodegeneration?
Daniel C. Berwick, Kirsten Harvey
Trends in Cell Biology (2011) Vol. 21, Iss. 5, pp. 257-265
Closed Access | Times Cited: 85
RISC in PD: the impact of microRNAs in Parkinson's disease cellular and molecular pathogenesis
Sabrina M. Heman-Ackah, Martina Hallegger, Mahendra S. Rao, et al.
Frontiers in Molecular Neuroscience (2013) Vol. 6
Open Access | Times Cited: 78
LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson's Disease, Where Do We Stand?
Jean‐Marc Taymans, Elisa Greggio
Current Neuropharmacology (2016) Vol. 14, Iss. 3, pp. 214-225
Open Access | Times Cited: 73
GTP binding regulates cellular localization of Parkinson's disease-associated LRRK2
Marian Blanca Ramírez, Antonio Jesús Lara Ordóñez, Elena Fdez, et al.
Human Molecular Genetics (2017) Vol. 26, Iss. 14, pp. 2747-2767
Open Access | Times Cited: 73
Leucine‐rich repeat kinase 2 regulates Sec16A at ER exit sites to allow ER –Golgi export
Hyun Jin Cho, Jia Yu, Chengsong Xie, et al.
The EMBO Journal (2014) Vol. 33, Iss. 20, pp. 2314-2331
Open Access | Times Cited: 68
Potential for therapeutic targeting of AKAP signaling complexes in nervous system disorders
Angela R. Wild, Mark L. Dell’Acqua
Pharmacology & Therapeutics (2017) Vol. 185, pp. 99-121
Open Access | Times Cited: 64
Dopaminergic neurons differentiating from LRRK2 G2019S induced pluripotent stem cells show early neuritic branching defects
Laurence Borgs, Elise Peyre, Philippe Alix, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 62
Astrocytic atrophy as a pathological feature of Parkinson’s disease with LRRK2 mutation
Paula Ramos-Gonzalez, Susana Mato, Juan Carlos Chara, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 49
Kinase inhibitors arrest neurodegeneration in cell and C. elegans models of LRRK2 toxicity
Chang Yao, William M. Johnson, Yuan Gao, et al.
Human Molecular Genetics (2012) Vol. 22, Iss. 2, pp. 328-344
Open Access | Times Cited: 74
The regulation and deregulation of Wnt signaling by PARK genes in health and disease
Daniel C. Berwick, Kirsten Harvey
Journal of Molecular Cell Biology (2013) Vol. 6, Iss. 1, pp. 3-12
Open Access | Times Cited: 71
LRRK2 directly phosphorylates Akt1 as a possible physiological substrate: Impairment of the kinase activity by Parkinson's disease-associated mutations
Etsuro Ohta, Fumitaka Kawakami, Makoto Kubo, et al.
FEBS Letters (2011) Vol. 585, Iss. 14, pp. 2165-2170
Closed Access | Times Cited: 70
Leucine-Rich Repeat Kinase 2 Is Associated With the Endoplasmic Reticulum in Dopaminergic Neurons and Accumulates in the Core of Lewy Bodies in Parkinson Disease
Jérémie Vitte, Sabine Traver, A. Maues de Paula, et al.
Journal of Neuropathology & Experimental Neurology (2010) Vol. 69, Iss. 9, pp. 959-972
Closed Access | Times Cited: 67

Scroll to top